A delivery company got a boost from a new partnership announcement on Friday, Nov. 14, 2025, while the termination of a clinical trial weighed on a pharmaceutical firm.
Palantir Stock Rises With Earnings Looming. There Is Talk of a Stock Split. Palantir has risen sharply over the past year alone, and many retail investors are eyeing a stock split. One way to protect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results